Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.
Clinical trials sponsored by Sichuan Kelun-biotech Biopharmaceutical Co., Ltd., explained in plain language.
-
New hope for colon cancer? trial tests targeted combo but stops early
Disease control TerminatedThis study tested whether adding a new drug called A140 to standard chemotherapy could help people with a certain type of advanced colorectal cancer (RAS wild-type) live longer without their cancer growing. The trial planned to include 570 people in China but was stopped early wi…
Phase: PHASE3 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New pill could help regrow hair in severe alopecia
Disease control TerminatedThis study tested a drug called KL130008 in adults with severe alopecia areata, a condition causing significant hair loss. The goal was to see if the drug could safely regrow hair on at least 80% of the scalp. The trial was stopped early, so results are limited.
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 02, 2026 11:40 UTC